-
Dual Luciferase Reporter Gene System for BMSC Studies
2026-09-02
Use the Dual Luciferase Reporter Gene System to connect MRF, FSHR, and cAMP-PKA-CREB regulation with quantitative promoter and pathway readouts in BMSCs. Its paired firefly and Renilla signals support normalization, while direct reagent addition streamlines mammalian cell culture luciferase assays and screening workflows.
-
Oleic Acid Workflows for Lipid Metabolism
2026-09-01
Use Oleic Acid (C18:1(9Z)) to build controlled lipid-loading, inflammation, and signaling assays rather than relying on undefined lipid mixtures. This guide translates hepatic ischemia-reperfusion research into practical dosing, controls, readouts, and troubleshooting strategies.
-
Carbenoxolone disodium: Practical Lab Guide
2026-09-01
Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is most appropriate for cell, tissue, and biochemical workflows with matched vehicle and orthogonal controls, not for selective in vivo efficacy claims or clinical interpretation.
-
NIID iPSC Model with NOTCH2NLC GGC Expansion
2026-08-31
The reference study establishes HZSMHCi002-A, a patient-derived induced pluripotent stem cell line carrying a pathogenic NOTCH2NLC GGC repeat expansion associated with neuronal intranuclear inclusion disease. Its documented pluripotency, genomic stability, donor matching, and three-germ-layer differentiation make it a useful starting point for mechanistic NIID research, although disease-specific phenotypes still require validation in differentiated cells.
-
Tamsulosin: From POUR Evidence to Assays
2026-08-31
Tamsulosin can connect clinical urinary-flow outcomes with mechanistic smooth muscle and GPCR studies. This article shows how the POUR meta-analysis can guide model selection, endpoints, controls, and compound handling without overextending clinical evidence.
-
CUX2 Neuron Loss Under Neuroinflammatory DNA Damage
2026-08-30
This study identifies accumulated DNA damage and insufficient double-strand-break repair as a mechanism underlying the selective loss of CUX2-positive layer 2/3 excitatory neurons in multiple sclerosis and mouse neuroinflammation models. Its combination of human lesion analysis, experimental inflammation, neuronal genetic perturbation, and interferon-γ modeling provides a framework for studying cell-type-specific neuronal vulnerability.
-
LncRNA MRF, FSHR, and BMSC Osteogenesis
2026-08-29
Ning et al. identify lncRNA MRF as a negative regulator of BMSC osteogenic differentiation and bone defect repair. Their data connect MRF with FSHR-dependent cAMP–PKA–CREB signaling, providing a mechanistic framework for studying lncRNA control of skeletal regeneration.
-
Fulvestrant (ICI 182,780) Workflow Guide
2026-08-28
Build reproducible ERα-antagonism experiments with Fulvestrant (ICI 182,780), from stock preparation and dose finding to MDM2 protein degradation and chemotherapy-sensitization assays. A reference-study translation also shows how the same antagonist can help dissect estrogen-linked immune and endoplasmic-reticulum-stress pathways without overstating cross-domain evidence.
-
Protease Inhibitor Cocktail: Assay Guide
2026-08-28
Learn how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), SKU K1010, supports more reliable protein-based endpoints in viability, proliferation, and cytotoxicity workflows. This scenario-driven guide covers compatibility, dosing, interpretation, and practical product selection.
-
Hyperoside, DHX9, and R-Loop Control in URSA
2026-08-27
This study identifies a mechanistic link between endometrial stromal cell senescence, unresolved R-loops, DHX9 dysfunction, and cGAS–STING activation in unexplained recurrent spontaneous abortion. By integrating patient tissues, a mouse model, and a human stromal-cell system, the authors show that hyperoside reduces embryo resorption and improves decidualization-associated defects, providing a framework for studying genome-integrity mechanisms in URSA.
-
Procainamide Hydrochloride Research Workflows
2026-08-27
Build reproducible cardiac, epigenetic, immunomodulatory, and combination-therapy assays around a well-characterized sodium channel modulator. Practical guidance covers concentration design, liposomal co-delivery, assay controls, and troubleshooting for stronger mechanistic conclusions.
-
iPSC Models of Schizophrenia and Bipolar Disorder
2026-08-26
This resource study established and characterized three human iPSC lines from two cousins diagnosed with schizophrenia or bipolar disorder and an unaffected cousin. The family-linked panel provides a practical platform for investigating neurodevelopmental mechanisms, although disease-specific phenotypes still require neural differentiation and functional validation.
-
RNA Pol II Loss Activates Apoptosis Beyond Transcription
2026-08-26
Harper et al. show that RNA polymerase II inhibition kills cells through active apoptotic signaling triggered by depletion of hypophosphorylated RNA Pol IIA, rather than through passive loss of transcriptional output. Their PDAR framework links RNA Pol II degradation to mitochondrial death signaling and offers a mechanistic lens for interpreting transcription-targeting drugs.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-25
FITC-Concanavalin A (ConA) Conjugate is a direct fluorescent probe for accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids. It supports cell-surface carbohydrate detection, tissue imaging, and flow cytometry, but should not be used as a universal glycan stain or as a probe for non-carbohydrate targets.
-
Sodium Citrate for Smarter SERS Assay Design
2026-08-25
Explore how Sodium citrate can shape solution chemistry without being mistaken for the structural driver of 3D SERS performance. This evidence-led guide connects citrate buffering and chelation with polymer pen lithography, assay controls, and reproducibility decisions.